British Journal of Oral and Maxillofacial Surgery
Volume 48, Issue 1 , Pages 30-36 , January 2010

Downregulation of Notch1 and its potential correlation with epidermal growth factor receptor signalling in tongue squamous cell carcinoma

  • Hong-jie Huang

      Affiliations

    • Department of Oral and Maxillofacial Surgery, School of Stomatology, Zhejiang University, No. 395 Yan-An St, Hangzhou 310006, PR China
    • School of Clinical Medicine, Hangzhou Normal University, PR China
  • ,
  • Fei-yun Ping

      Affiliations

    • The Second Affiliated Hospital of Zhejiang University, PR China
  • ,
  • Ji-an Hu

      Affiliations

    • School of Stomatology, Zhejiang University, PR China
  • ,
  • Shi-fang Zhao

      Affiliations

    • Department of Oral and Maxillofacial Surgery, School of Stomatology, Zhejiang University, No. 395 Yan-An St, Hangzhou 310006, PR China
    • Corresponding Author InformationCorresponding author. Tel.: +86 571 87217388; fax: +86 571 87217433.

,Accepted 6 March 2009.

References 

  1. Miele L. Notch signaling. Clin Cancer Res. 2006;12:1074–1079
  2. Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood. 2006;107:2223–2233
  3. Talora C, Sgroi DC, Crum CP, Dotto GP. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev. 2002;16:2252–2263
  4. Pear WS, Aster JC. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol. 2004;11:426–433
  5. Axelson H. Notch signaling and cancer: emerging complexity. Semin Cancer Biol. 2004;14:317–319
  6. Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumor suppressor?. Nat Rev Cancer. 2003;3:756–767
  7. Maillard I, Pear WS. Notch and cancer: best to avoid the ups and downs. Cancer Cell. 2003;3:203–205
  8. Weng AP, Aster JC. Multiple niches for Notch in cancer: context is everything. Curr Opin Genet Dev. 2004;14:48–54
  9. Sjölund J, Manetopoulos C, Stockhausen MT, Axelson H. The Notch pathway in cancer: differentiation gone awry. Eur J Cancer. 2005;41:2620–2629
  10. Doroquez DB, Rebay I. Signal integration during development: mechanisms of EGFR and Notch pathway function and cross-talk. Crit Rev Biochem Mol Biol. 2006;41:339–385
  11. Lefort K, Dotto GP. Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression. Semin Cancer Biol. 2004;14:374–386
  12. Patten BA, Peyrin JM, Weinmaster G, Corfas G. Sequential signaling through Notch1 and erbB receptors mediates radial glia differentiation. J Neurosci. 2003;23:6132–6140
  13. Sundaram MV. The love-hate relationship between Ras and Notch. Genes Dev. 2005;19:1825–1839
  14. Kolev V, Mandinova A, Guinea-Viniegra J, Hu B, Lefort K, Lambertini C, et al. EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol. 2008;10:902–911
  15. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006;366:2–16
  16. Zimmermann M, Zouhair A, Azria D, Ozsahin M. The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications. Radiat Oncol. 2006;(May):1–11
  17. Hiraishi Y, Wada T, Nakatani K, Negoro K, Fujita S. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas. Pathol Oncol Res. 2006;12:87–91
  18. Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, et al. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol. 2007;43:193–198
  19. Kalyankrishna S, Grandis JR. Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol. 2006;24:2666–2672
  20. Choong NW, Cohen EE. Epidermal growth factor receptor directed therapy in head and neck cancer. Crit Rev Oncol Hematol. 2006;57:25–43
  21. Zhao SF, Tong XY, Zhu FD. Nitric oxide induces oral squamous cell carcinoma cells apoptosis with p53 accumulation. Oral Oncol. 2005;41:785–790
  22. Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB, et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res. 2001;61:3200–3205
  23. Qi R, An H, Yu Y, Zhang M, Liu S, Xu H, et al. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res. 2003;63:8323–8329
  24. Duan L, Yao J, Wu X, Fan M. Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells. Biol Cell. 2006;98:479–490
  25. Lefort K, Mandinova A, Ostano P, Kolev V, Calpini V, Kolfschoten I, et al. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases. Genes Dev. 2007;21:562–577

PII: S0266-4356(09)00090-4

doi: 10.1016/j.bjoms.2009.03.008

British Journal of Oral and Maxillofacial Surgery
Volume 48, Issue 1 , Pages 30-36 , January 2010